Drawing for MAXYGEN

USPTO serial 87209847

MAXYGEN

Reviewed by CopyMark Law Group

Reg. 5376411Status 702Renewal
Filing date
Status date
Registration date
Jan 9, 2018
Examiner
EVANKO, PATRICIA MALESARDI
Law office
TMO LAW OFFICE 119

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with MAXYGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miguel C. Danielson

Miguel C. Danielson DANIELSON LEGAL LLCOne Mifflin Place, Suite 400ATTN: TRADEMARK ADMINISTRATORCAMBRIDGE, MA 02138

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological research and development services in the field of protein and enzyme activity; scientific and technological research and development services in the field of biologics; design and development of proteins and enzymes for use in pharmaceuticals, biotechnology, and medical and veterinary diagnosticsACTIVEJun 8, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 16, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 16, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 16, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 17, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Jan 9, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 9, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 7, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 6, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 17, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 16, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 1, 2017IUAFUSE AMENDMENT FILED—
Nov 1, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 9, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 31, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 30, 2017DOCKASSIGNED TO EXAMINER—
Oct 26, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance